A B S T R A C T Normal subjects given 60 mg of prednisone orally at 8:00 a.m. developed a transient lymphopenia at 2:00 p.m. To define the populations of lymphocytes affected the number and type of lymphocytes in the peripheral blood were assayed. "Late" and "early" spontaneous sheep red blood cell rosettes were used as markers for thymus-derived (T) lymphocytes and one of its subpopulations, respectively. Receptors for aggregated gammaglobulin and complement identified bursal-equivalent or bone marrow-derived (B) lymphocytes and one of its subpopulations, respectively. 6 h after administration of 60 mg of prednisone, the blood samples showed a decrease in proportion of T cells from 69.2±2.1% to 55.9±2.8% (average+SE) and an increase in B-cell proportion from 21.3±2.0% to 44.8± 4.1%. The changes of "early" rosettes and complement receptor lymphocytes also paralleled these. In all cases the absolute numbers of T cells and of B cells were decreased by prednisone. The density gradient distribution of the lymphocytes did not change after prednisone. These data indicate that both T and B lymphocytes are affected by the prednisone but that the T cell lymphopenia was more pronounced. The lymphopenia might reflect either sequestration in the marrow and/or transient arrest of recirculation.
INTRODUCTION
Corticosteroids are a group of drugs commanding much attention in immunological investigations. They have profound effects on lymphocytes in steroid-sensitive species (1), including differential effects on lymphocyte subpopulations in mice and rats.
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Received for publication 9 August 1973 and in revised form 15 October 1973. This group of drugs is also a frequently employed therapeutic agent in the treatment of many human diseases, some of which are immunologically aberrant. Normal human lymphocytes, however, are considered relatively resistant to these drugs because human lymphocytes are relatively refractory to lysis by these drugs in vitro (2) .
Here, we define a transient lymphopenia in normal subjects receiving prednisone or hydrocortisone and analyze the steroid-induced changes in peripheral blood lymphocytes. Methods employed include (a) identification and quantitation of thymus-derived (T)' and bursal-equivalent or bone marrow-derived (B) lymphocytes; and (b) density distribution of lymphocytes on discontinuous Ficoll density gradients.
METHODS
Subjects. Subjects were fully informed, consenting volunteers, most of whom belonged to the staff of our laboratories. All received the drug orally at 8 :00 a.m. Blood was collected just before ingestion, 6 h later (2:00 p.m.), and at other intervals where indicated. The drug preparation used was prednisone (Parke-Davis & Co., Detroit, Mich.; biochemical name: 17a,21-dihydroxypregna-1,4,diene-3,11,20-trione). Six normal subjects (three men and three women within the same age group as those taking prednisone) served as controls. These control subjects did not take prednisone or any other medication. Blood was also taken at 8:00 a.m. and 2:00 p.m. for similar studies. (4) . SRBC were sensitized by 1: 200 dilution of rabbit IgM anti-SRBC antibodies (Cordis Laboratories, Miami, Fla.) and then by 1:10 dilution of human serum (fresh frozen) which had been adsorbed with SRBC. The SRBC were then resuspended in concn. of 1 X 108 per ml in HBSS. 0.4 ml of this was mixed with 0.4 ml of lymphocytes and incubated at 37°C with 2 drops of latex particles for 15 min. They were then put on horizontal rotator at 37°C for 15-30 min. Unless specified, tests were done in triplicate.
The method for detecting lymphocytes bearing receptors for aggregated gammaglobulin (AggG) was adapted from that reported by Dickler and Kunkel (5) . Lymphocytes were first incubated with aggregated human globulin fraction II and then stained with fluorescein isothiocyanateconjugated anti-human gammaglobulin antibodies (Custom Reagent Lab, San Diego, Calif.). Cells were counted with epifluorescent and phase-contrast microscope (Zeiss Ultraphadt, Carl Zeiss, Inc., New York) under X100 oil immersion objective. Note that this method actually identified cells that have receptors for AggG as well as cells with surface immunoglobulins. They will all be grouped as Agg-GRL cells for abbreviation.
Density distribution of lymphocytes. Density distribution was assessed by equilibrium centrifugation on a discontinuous Ficoll density gradient. Details of the method have been reported (6) . The following concn. of Ficoll solutions were used: 5, 12, 15, 19, 22, 25, and 30%c. Cells distributed at the interfaces after centrifugation were designated by the concn. of the solutions immediately above it. For example, the layer between 25 and -30%7 is named 2 Here, the term "early rosette" is used to substitute for "active rosette" used by Wybran and Fudenberg (9) . The former term contrasts these with late rosettes and bears no other connotations. the 25% layer. The number of cells in each layer is calculated as the percentage of the total number of cells in the 5-25% layers. We noticed that the density distribution may vary depending on the batch of Ficoll (Pharmacia Fine Chemicals, Inc., Uppsala, Sweden) used. All distributions shown in Table ' VI are from lot 5534.
Statistics. All values shown are means-SE. The Student t test was employed and differences were considered significant if P < 0.05.
RESULTS
Lymphocyte conc. In the initial experiments six subjects were given 30 mg and four were given 5 mg of prednisone orally at 8:00 a.m. Blood specimens were obtained at time zero, 4, 5, 6 and 24 h. All counts were done in duplicate. With the 30 mg dose, a large decrease in the absolute concn. of both lymphocytes and monocytes at the fourth hour was reversed at the 24th hour (Table I). After the 5 mg dose, a similar decrease occurred, but the changes were less marked. Subsequently, only zero and sixth hour samples were assayed unless otherwise specified.
Further investigations of eight other subjects (Table  II) revealed that there was invariably a lymphopenia after 30 mg of prednisone. The lymphocyte concn. at the sixth hour was only 32+4% of the preprednisone concn. at 8:00 a.m. (P < 0.001). The total WBC count, on the other hand, was 6,481+655/mm3 initially and 9,100±721 at the sixth hour (P < 0.02), as expected from the wellknown capacity of prednisone to cause granulocytosis (7).
13 subjects each received a 60-mg dose of prednisone at 8:00 a.m. instead of a 30-mg dose. In nine of them the total WBC concn. was increased at the sixth hour. All 13 developed lymphopenia (32±5% of the initial count). The extent of leucocytosis and lymphopenia at 6 h was similar to that produced by the 30-mg dose (Table II) Effect of Prednisone on WBC and Lyr tions of late rosettes and AggGRL, which were abnormal at 6 h, had returned to normal after 24 h (Table IV) .
Changes in the absolute concn. of early and late SRBC rosettes, AggGRL and CRL were calculated (Table V) . All four types of cells were markedly decreased poststeroid. However they were affected to different extents. Only 24±4.9% of the late rosettes remained at 2:00 p.m., whereas 52.2±9.4% of the AggGRL were still present at that time (P < 0.02). The the early SRBC rosettes and CRL paralleled these changes (Table V) .
The normal variation was studied in six subjects who did not receive the prednisone. Blood was taken at 8:00 a.m. and 2:00 p.m. There was minimal variation of WBC and lymphocyte concn. and T-and B-cell ratio in peripheral blood compared to those who were given prednisone (Tables II and III) .
Density distribution of lymphocytes 6 h after administration of 60 mg of prednisone was assayed in five subjects. Lymphocytes remained predominantly at layers 19-25% (Table VI) .
Hydrocortisone and plasma cortisol levels. One subject received 240 mg hydrocortisone orally at 8:00 a.m. Blood was collected just before drug administration and at 1, 2, 3, 4 and 6 h thereafter. Plasma cortisol levels were assayed in the UCLA Clinical Laboratories (normal levels 5-25 /g/100 ml). Serial WBC and lymphocyte concn. were also assayed. The plasma cortisol level was 23 Lg/100 ml at 8:00 a.m. and reached a peak of 220 b'g/ 100 ml at the second hour. In contrast, the absolute lymphocyte concn. declined slowly from 1,640 to 1,100/ mm3 during the first 3 h, reaching a low of 266/mm3 at the fourth hour (Fig. 1) . The total WBC count actually rose from 4,700/mm3 to 13,300/mm8 during the first 4 h, and the proportion of lymphocytes fell from 35 to 2%. These results were very similar to those reported elsewhere (8) . DISCUSSION That transient lymphopenia generally follows corticosteroid administration to children was recently documented (9). In our group of adult subjects, 30-mg or 60-mg doses of prednisone depressed the lymphocyte concn. in peripheral blood (Table II) . The cause of this lymphopenia in man is obscure. Here we probed the question by analyzing the changes in lymphocyte characteristics after corticosteroid challenge. Preliminary experiments in a small number of subjects after 30 mg of prednisone were equivocal (results not shown), but statistically significant differences were observed after 60 mg (Table III) .
Membrane markers of lymphocyte subpopulations. Ca-
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Yn1, Clements, Paulus, Peter, Levy, and Barnett (16) . In both mice and rats, the predominant effect of corticosteroids is on T cells, and the ultimate consequence is similar to the human situation as demonstrated by us, in that there is a depletion of T relative to B cells in the peripheral blood.
Similar lymphopenia occurred after challenge with hydrocortisone ( Fig. 1) , suggesting that this effect may be common to most corticosteroids. The relationship between plasma cortisol levels and lymphocyte concn. showed that maximum lymphopenia took place 3 h after plateau cortisol levels had been reached. This lag may represent the time necessary to alter the lymphocyte function. The other possibility is that the lymphocytes were already affected at that instance, but it took 3 h for them to enter the lymphoid organs or bone marrow. Then, as a result of changes in reentry mechanism, they could not return to the blood stream. If so, prednisone challenge may serve as a tool to investigate lymphocyte dynamics in vivo.
The clinical significance of this transient lymphopenia has not yet been explored. In particular, study of sub- 
